Seeking Solutions for Large-Scale GMP Viral Vector Manufacturing: Innovation in manufacturing technologies must occur to ensure the availability of gene and cell therapies.

Bibliographic Details
Published in:BioPharm International Vol. 32; no. 9; pp. 26 - 29
Main Author: CHALLENER, CYNTHIA A.
Format: Journal Article
Published: MJH Life Sciences Sep2019
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=138564860&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 138564860
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1542166X
        5NE
      jtl: BioPharm International
      issn: 1542166X
      maglogo: N
    pubinfo:
      dt: Sep2019
      vid: 32
      iid: 9
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        138564860
        138564860
      ppf: 26
      ppct: 3
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Seeking Solutions for Large-Scale GMP Viral Vector Manufacturing: Innovation in manufacturing technologies must occur to ensure the availability of gene and cell therapies.
      aug:
        au: CHALLENER, CYNTHIA A.
      sug:
      pubtype: Trade Publication
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N